BostonGene Corporation is a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile.